Search

Your search keyword '"Kelly L. Wu"' showing total 4 results
Start Over Author "Kelly L. Wu" Journal journal of palliative medicine
4 results on '"Kelly L. Wu"'

1. End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Author

Marisa M. Salazar, Lori DeCook, Ayan Sen, Richard J. Butterfield, Nan Zhang, Kelly L. Wu, David J. Vanness, and Nandita Khera

Subjects
Terminal Care, medicine.medical_specialty, Palliative care, Hematopoietic cell, business.industry, Palliative Care, Hematopoietic Stem Cell Transplantation, General Medicine, humanities, Transplantation, High morbidity, Hospice Care, surgical procedures, operative, Anesthesiology and Pain Medicine, medicine, Humans, In patient, Intensive care medicine, business, End-of-life care, General Nursing, Retrospective Studies
Abstract

Background: Patients receiving allogeneic hematopoietic cell transplantation (HCT) have high morbidity and mortality risk, but literature is limited on factors associated with end-of-life (EOL) car...

Published
2022

2. Resurgence of Eating Disorders with Olanzapine

Author

Elise C. Carey, Molly A. Feely, Amanda K. Lorenz, Kelly J. Christensen, Jacob J. Strand, and Kelly L. Wu

Subjects
Olanzapine, medicine.medical_specialty, Palliative care, Side effect, Nausea, media_common.quotation_subject, Appetite, Antineoplastic Agents, medicine, Humans, Psychiatry, Bulimia Nervosa, General Nursing, media_common, Aged, Ovarian Neoplasms, business.industry, Palliative Care, General Medicine, medicine.disease, Eating disorders, Anesthesiology and Pain Medicine, Treatment Outcome, Female, medicine.symptom, business, medicine.drug, Antipsychotic Agents
Abstract

Olanzapine is commonly utilized in palliative care for the treatment of nausea, and a known side effect of olanzapine is increased appetite. Olanzapine is also known to cause re-emergence of eating disorders (EDs) in patients utilizing olanzapine for its antipsychotic effects. It is unclear to what extent this may also occur in patients with serious/life-limiting illness.We present a case of a 70-year-old female with recurrent ovarian cancer and a history of bulimia nervosa (BN) that developed resurgence of her BN after initiation of olanzapine for cancer-associated nausea. Her BN resolved with reducing the dose of olanzapine.It is important to recognize that recurrence of EDs can occur when using olanzapine in the palliative care setting.

Published
2018

3. Drug-Drug Interactions between Methadone and Apixaban

Author

Kelly L. Wu, Virginia H. Thompson, and Jacob S. Strand

Subjects
Drug, Narcotics, medicine.medical_specialty, Pyridones, media_common.quotation_subject, 02 engineering and technology, 01 natural sciences, 020210 optoelectronics & photonics, 0202 electrical engineering, electronic engineering, information engineering, medicine, Humans, Drug Interactions, Intensive care medicine, General Nursing, media_common, business.industry, General Medicine, 0104 chemical sciences, 010404 medicinal & biomolecular chemistry, Anesthesiology and Pain Medicine, Pyrazoles, Apixaban, business, Methadone, medicine.drug, Factor Xa Inhibitors
Published
2017

4. The impact of a palliative care team on residents' experiences and comfort levels with pediatric palliative care

Author

Jennifer Friderici, Kelly L Wu, and Sarah L. Goff

Subjects
Adult, Male, medicine.medical_specialty, Health Knowledge, Attitudes, Practice, Palliative care, Attitude of Health Personnel, education, MEDLINE, Pediatrics, Nursing, Surveys and Questionnaires, medicine, Humans, Comfort levels, Child, General Nursing, Accreditation, Patient Care Team, Academic year, business.industry, Palliative Care, Internship and Residency, General Medicine, Pediatric palliative care, United States, Anesthesiology and Pain Medicine, Palliative care.team, Family medicine, Female, business, End-of-life care
Abstract

8,600 children are eligible for palliative care services each day in the US, yet many pediatric residents and pediatricians do not feel comfortable providing palliative/end of life care.To evaluate the impact of a palliative care team (PCT) on pediatric and internal medicine/pediatric (IM/Peds) residents knowledge, comfort level and experience providing pediatric palliative care (PPC).Electronic 32-item questionnaire.Pediatric and IM/Peds residents at ACGME accredited programs during the 2011-2012 academic year.Residents' PPC training, knowledge, comfort levels and experiences.Nearly two-thirds of 294 respondents (63.6%; 95% CI: 58.2, 69.1) selected a description of PPC that describes palliative care as starting at the time of diagnosis regardless of treatment goals. Participants who reported the presence of a PCT at their institution selected this accurate description of PPC more often than those who did not report the presence of a PCT (72.3% vs. 53.3%; p0.001, Fisher's Exact Test). Overall, 55.3% (95% CI: 49.2, 61.3) were comfortable providing PPC. Reporting the presence of a PCT was also associated with more comfort in providing PPC (p0.01).Reported presence of a PCT may be associated with greater resident comfort in providing PPC and a more accurate understanding of PPC. There remains ample opportunity to educate pediatric and IM/Peds residents in PPC.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results